EPN 0.00% 2.4¢ epsilon healthcare limited

Ann: THC Global Granted Manufacture Licence, page-3

  1. 15,727 Posts.
    lightbulb Created with Sketch. 1793
    THC Global Granted Cannabis Manufacture Licence Key Points: • THC Global granted Manufacture Licence for production of extracts and tinctures of cannabis and cannabis resin • Completion of the ‘Farm to Pharma’ vertical integration model • THC Global now holder of all three cannabis licences within Australia – Cannabis Research Licence, Medicinal Cannabis Licence, and Manufacture Licence in addition to export licence • Pathway for development of a new generation of proprietary medicinal cannabis products • Cultivation of medicinal cannabis plant material already commenced THC Global Group Limited (THC Global or the Company) (ASX:THC) is pleased to advise that THC Global, through its wholly owned subsidiary Canndeo Limited, has been granted a Manufacture Licence for the production of extracts and tinctures of cannabis and cannabis resin from the Australian Office of Drug Control. The granting of this Manufacture Licence is a significant milestone, representing the completion of the Company’s ‘Farm to Pharma’ vertical integration strategy, with the Company now able to cultivate its own proprietary strains, process cannabis plant material, and manufacture extracts and tinctures from cannabis. The receipt of the Manufacture Licence underlines THC Global’s position to be a leader in the medicinal cannabis sector within Australia as the Company prepares to commence delivery of Australian grown, Australian manufactured medicinal cannabis products to domestic patients and the global export market.
 
watchlist Created with Sketch. Add EPN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.